Currently prescribed drugs in the UK that could upregulate or downregulate ACE2 in COVID-19 disease: a systematic review

OBJECTIVE: To review evidence on routinely prescribed drugs in the UK that could upregulate or downregulate ACE2 and potentially affect COVID-19 disease. DESIGN: Systematic review. DATA SOURCE: MEDLINE, EMBASE, CINAHL, the Cochrane Library and Web of Science. STUDY SELECTION: Any design with animal...

Descripción completa

Detalles Bibliográficos
Autores principales: Dambha-Miller, Hajira, Albasri, Ali, Hodgson, Sam, Wilcox, Christopher R, Khan, Shareen, Islam, Nazrul, Little, Paul, Griffin, Simon J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490921/
https://www.ncbi.nlm.nih.gov/pubmed/32928868
http://dx.doi.org/10.1136/bmjopen-2020-040644

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490921/
https://www.ncbi.nlm.nih.gov/pubmed/32928868
http://dx.doi.org/10.1136/bmjopen-2020-040644

Ejemplares similares